논문KCI 등재
Letter regarding “Risk factors in nonalcoholic fatty liver disease”
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (3)
- Eunji Ko, "Risk factors in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.79~85 (2023), 대한간학회
- World Health Organization, "Guideline: Sugars intake for adults and children", World Health Organization, ~ (2015)
- Huang Y, "Dietary sugar consumption and health : umbrella review", BMJ, 381, pp.e071609~ (2023)
관련 논문AI추천
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”전대원, Eileen L. Yoon대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제4호Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”Hyun Wook Han, Seogsong Jeong, Su Kyoung Lee, Yohwan Lim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”김문영, 백순구, Seul Ki Han대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”Hye Won Lee대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence to editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal realworld study”Mindie H. Nguyen, Vy H. Nguyen대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (22건)
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernityJoon Ho Moon, 김원, Gi-Ae Kimpp. 831-843Waiting for the changes after the adoption of steatotic liver disease전대원, Eileen L. Yoonpp. 844-850Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapyTakako Inoue, Yasuhito Tanaka, Takehisa Watanabepp. 851-868Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harmYao-Chun Hsu, Jia-Horng Kao, Cheng-Hao Tsengpp. 869-890Hepatorenal syndrome: Current concepts and future perspectivesChan-Young Jung, Jai Won Changpp. 891-908